Chemotherapy of myeloma: Drug combinations versus single agents, an overview, and comments on acute leukemia in myeloma

This publication has 11 references indexed in Scilit:

• Multiple myeloma in central Norway 1981-1982: A randomized clinical trial of 5-drug combination therapy versus standard therapy
  Scandinavian Journal of Haematology, 2009
• RISK OF THERAPY-RELATED LEUKAEMIA AND PRELEUKAEMIA AFTER HODGKIN'S DISEASE
  The Lancet, 1987
• A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis
  British Journal of Cancer, 1987
• Phase III study of intermittent 5‐drug regimen (VBCMP) versus intermittent 3‐drug regimen (VMP) versus intermittent melphalan and prednisone (MP) in myelomatosis
  Scandinavian Journal of Haematology, 1985
• Chemotherapy for multiple myeloma
  Cancer, 1984
• Alternating combination chemotherapy and levamisole improves survival in multiple myeloma: a Southwest Oncology Group Study.
  Journal of Clinical Oncology, 1983
• The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute Leukemia
  New England Journal of Medicine, 1979
• Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation.
  The Journal of Experimental Medicine, 1979
• Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol
  The American Journal of Medicine, 1977
• Mouse Myeloma
  Archives of internal medicine (1960), 1975